Artículo
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.
Research record from J Clin Oncol, 2026-05-21. PMID 42166704.
Loading
Busque productos, empresas, pruebas y guías: pase de la consulta a la solicitud de cotización en un solo lugar.
Artículo
Research record from J Clin Oncol, 2026-05-21. PMID 42166704.
Artículo
Research record from Eur J Clin Microbiol Infect Dis, 2026-10-26. PMID 42928317.
Artículo
Research record from Front Cell Infect Microbiol, 2026-03-12. PMID 41909847.
Artículo
Research record from Int J Infect Dis, 2026-07-27. PMID 42508520.
Artículo
Refreshing a near-patient molecular portfolio: which use cases justify POCT, the quality discipline it demands, and complementing the central laboratory.
Artículo
Research record from Antimicrob Steward Healthc Epidemiol, 2026-08-05. PMID 42564991.
Artículo
Research record from BMC Infect Dis, 2026-06-30. PMID 42380877.
Artículo
Research record from Open Forum Infect Dis, 2026-07-04. PMID 42444789.
Glossary Term
Chemicals that are added to drug products to prolong shelf life and maintain sterility. Protection of formulations, especially aqueous solutions, against microbial growth requires use of either antibacterial or antifungal preservatives. Generally, such agents are active against either bacteria or fungi but a few are active against both. The antimicrobials include but not limited to chlorobutanol, benzyl alcohol, sodium benzoate, sorbic acid, and phenol. The antioxidizing agents include butylated hydroxytoluene, hydroxyanisole, propyl gallate, and sulfites. The necessary addition of preservatives for both safety and economy sometimes has been associated with significant adverse effects in certain patient populations.
Artículo
Research record from Am J Infect Control, 2026-09-17. PMID 42753817.
Artículo
Research record from Sci Rep, 2026-04-08. PMID 41951723.
Artículo
Research record from STAR Protoc, 2026-03-31. PMID 41920744.